SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-382849
Filing Date
2015-11-20
Accepted
2015-11-20 07:12:59
Documents
7
Period of Report
2015-11-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d215091d8k.htm 8-K 25583
2 EX-10.1 d215091dex101.htm EX-10.1 55856
3 EX-10.2 d215091dex102.htm EX-10.2 41208
4 EX-10.3 d215091dex103.htm EX-10.3 95091
5 EX-99.1 d215091dex991.htm EX-99.1 8786
6 GRAPHIC g215091avalanche.jpg GRAPHIC 18710
7 GRAPHIC g215091avalanche2.jpg GRAPHIC 14695
  Complete submission text file 0001193125-15-382849.txt   274114
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 151244974
SIC: 2836 Biological Products, (No Diagnostic Substances)